|
WO2021035037A1
|
|
Method to increase systemic blood pressure in shock
|
|
WO2021035048A1
|
|
Use of inhibitors of yap and sox2 for the treatment of cancer
|
|
WO2021034594A2
|
|
Large dzyaloshinskii - moriya interaction and perpendicular magnetic anisotropy induced by chemisorbed species on ferromagnets
|
|
WO2021025935A1
|
|
Dna-fish method for measurement of telomere length
|
|
WO2021003121A1
|
|
Portable folding infant radiant warmer
|
|
WO2020252175A1
|
|
Optimized fragmentation for quantitative analysis of fucosylated n-glycoproteins by lc-ms-mrm
|
|
WO2020252198A1
|
|
Methods for reducing tumor progression and fibrosis and increasing adaptive immunity in malignancies
|
|
WO2020240525A1
|
|
Assessing diseases by analyzing gait measurements
|
|
US2020383941A1
|
|
USE OF Kv11.1 CHANNEL INHIBITORS FOR TREATMENT OF PULMONARY HYPERTENSION
|
|
US10902955B1
|
|
Detecting COVID-19 using surrogates
|
|
WO2020232133A1
|
|
Methods of treating gastrointestinal cancers and tumors thereof using combination therapy
|
|
WO2020226919A1
|
|
Use of inhibitors of yap/taz for the treatment of cancer
|
|
US2020319163A1
|
|
Methods and compositions overcoming cancer cell immune resistance
|
|
US2020265083A1
|
|
Predicting the popularity of a song based on harmonic surprise
|
|
US2020239959A1
|
|
Plasma MicroRNA Markers of Upper Limb Recovery Following Human Stroke
|
|
WO2020106825A1
|
|
Compositions and methods for treating neurodegenerative, myodegenerative, and lysosomal storage disorders
|
|
WO2020097054A1
|
|
Treating non-alcoholic steatohepatitis with cck inhibitors
|
|
US2021125119A1
|
|
Specialized computing environment for co-analysis of proprietary data
|
|
WO2021080615A1
|
|
Specialized computing environment for co-analysis of proprietary data
|
|
US2020356578A1
|
|
Cache optimization via topics in web search engines
|
